Since there is no significant variation in tumor biomarkers (i.e., estrogen or progesterone receptor positivity), the underlying cancer biology could be reinforced to be similar to menopausal status with little hormonal impact on the tumor traits. The gene discussed is PGR; the disease is neoplasm.